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ABSTRACT
Objective To compute the burden of cancer attributable to
current and former alcohol consumption in eight
European countries based on direct relative risk
estimates from a cohort study.
Design Combination of prospective cohort study with
representative population based data on alcohol
exposure.
Setting Eight countries (France, Italy, Spain, United
Kingdom, the Netherlands, Greece, Germany, Denmark)
participating in the European Prospective Investigation
into Cancer and Nutrition (EPIC) study.
Participants 109118 men and 254870 women, mainly
aged 37-70.
Main outcome measures Hazard rate ratios expressing
the relative risk of cancer incidence for former and current
alcohol consumption among EPIC participants. Hazard
rate ratios combined with representative information on
alcohol consumption to calculate alcohol attributable
fractions of causally related cancers by country and sex.
Partial alcohol attributable fractions for consumption
higher than the recommended upper limit (two drinks a
day for men with about 24 g alcohol, one for women with
about 12 g alcohol) and the estimated total annual
number of cases of alcohol attributable cancer.
Results If we assume causality, among men and women,
10% (95%confidence interval 7 to 13%) and3% (1 to 5%)
of the incidence of total cancer was attributable to former
and current alcohol consumption in the selected
European countries. For selected cancers the figures were
44% (31 to 56%) and 25% (5 to 46%) for upper
aerodigestive tract, 33% (11 to 54%) and 18% (−3 to
38%) for liver, 17% (10 to 25%) and 4% (−1 to 10%) for
colorectal cancer for men and women, respectively, and
5.0% (2 to 8%) for female breast cancer. A substantial
part of the alcohol attributable fraction in 2008 was
associated with alcohol consumption higher than the
recommended upper limit: 33037 of 178578 alcohol
related cancer cases in men and 17470 of 397043
alcohol related cases in women.
Conclusions In western Europe, an important proportion
of cases of cancer can be attributable to alcohol
consumption, especially consumption higher than the
recommended upper limits. These data support current
political efforts to reduce or to abstain from alcohol
consumption to reduce the incidence of cancer.
INTRODUCTION
Alcohol consumption is thought to account for a sub-
stantial number of deaths worldwide, with Europe and
America showing the highest alcohol attributable frac-
tions of 6.5% and 5.6%, respectively.1 Chronic dis-
eases, especially cancer, contribute markedly to this
burden. In 2007 the InternationalAgency forResearch
on Cancer (IARC) added two of the most common
cancers—female breast and colorectal cancer—to the
list of cancers causally related to alcohol, which
previously consisted of oral cavity, pharynx, larynx,
oesophagus, and liver cancer.2 Although alcohol con-
sumption is a major risk factor for cancer incidence,3
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and Europe is among the regions with the highest per
capita alcohol consumption, detailed information on
the fractions of cancer that are attributable to alcohol
consumption based on direct empirical evidence for
the different cancer sites is sparse,4 5 and systematic
and comparable estimations across European coun-
tries are lacking. Moreover, previous estimates of the
alcohol attributable fractions refer to the burden from
current alcohol consumption but do not consider the
risk of former alcohol consumption. Also, in 2007 the
World Cancer Research Fund/American Institute for
Cancer Research published recommendations on the
maximum recommended daily alcohol consumption.6
We do not know howmuch of the burden of incidence
of cancer is attributable to alcohol and occurs because
of consumption higher than the recommended upper
limit.
We estimated the total (current and former alcohol
consumption) and partial (alcohol consumption higher
than the recommended upper limit) alcohol attributa-
ble fractions for the incidence of total and specific can-
cers related to alcohol in eight European countries
based on hazard rate ratios from the European Pro-
spective Investigation into Cancer and Nutrition
(EPIC) study and linked those alcohol attributable frac-
tions to incidences of cancer to estimate the annual
absolute number of cancer cases attributable to alcohol
in these countries.
METHODS
Study population
The EPIC study is a multicentre prospective cohort
study that, from 1992 to 2000, recruited about
520 000 randomly selected men and women aged
mainly 35-70 from 10 European countries.7 8 Eligible
participantswere selected from the general population,
except in France, where selection was based on mem-
bers of the health insurance system or state school
employees, and in Utrecht (the Netherlands), where
selection was based on women attending screening
for breast cancer. Participants gave informed consent
and completed questionnaires on diet and lifestyle.
The present analyses included participants free from
cancer at recruitment and who were not in the top or
bottom1%of the ratio of energy requirement to energy
expenditure (n=478 478). Participants with incomplete
information on alcohol consumption at recruitment or
in the past (n=114 481) and missing dietary informa-
tion (n=9) were excluded, leaving 363 988 men and
women from France, Italy, Spain, the Netherlands,
United Kingdom, Greece, Germany, and Denmark.
France and Utrecht enrolled only women. As we
wanted to consider the risk of cancer incidence asso-
ciated with former alcohol consumption, we had to
exclude the centres of Norway, Sweden, Bilthoven,
and Naples because they did not have information on
past consumption.
Alcohol consumption at recruitment (in grams per
day) was measured with a validated dietary question-
naire assessing frequency and portion size of beer/
cider, wine, spirits, and fortified wine covering the
12 months before recruitment.9-11 Consumption in
the past was assessed as self reported consumption of
beer, wine, and spirits at the ages of 20, 30, 40, and 50.
Based on consumption in the past and at recruitment
we distinguished between never (no consumption in
the past and no consumption at recruitment), former
(consumption in the past but no consumption at
recruitment), and lifetime consumers (consumption
in the past and at recruitment). For lifetime consumers,
consumption as applied in this analysis reflects the past
years’ consumption before recruitment.
We obtained information on incidence of cancer
through record linkage with regional cancer registers
in countries with passive follow-up (Denmark, Italy,
the Netherlands, Spain, UK) or by a combination of
methods including medically verified self reports of
the participant or the next of kin, cancer or pathology
registers, health insurance records, or death certificates
in countries with active follow-up (France, Germany,
Greece). The follow-up ended between 2002 and
2005,12 and loss to follow-up was relatively low, with
<2% in all countries irrespective of active or passive
follow-up. We investigated cancers with a causal asso-
ciation to alcohol consumption3 (colorectal (C18-21,
ICD-O (international classification of diseases-onco-
logy, 2nd revision), upper aerodigestive tract (C00-
10, C12-15, C32), liver (C22), female breast (C50)), as
well as total cancer (C00-C80, except C44 skin cancer)
and alcohol related cancers combined (upper aero-
digestive tract, colorectal, liver, and, for women,
female breast cancer). ICD codes of cancer end points
were in accordance with the GLOBOCAN-2008 can-
cer definitions.13
Statistical analysis
We combined hazard rate ratios derived from the
EPIC study with representative data on alcohol con-
sumption from the general population. Cox propor-
tional hazard regressions were applied to compute
hazard rate ratios14 during a mean follow-up time of 8.
8 years for alcohol consumption among lifetime con-
sumers per 12 g/day increment (equivalent to one
drink of any alcoholic beverage) and for former com-
pared with never consumers and incidence of first pri-
mary cancer. Age was used as the underlying time
variable with entry and exit time defined as the partici-
pant’s age at recruitment and age at diagnosis of cancer
or at censoring, respectively. Results on some single
cancer outcomes have been published earlier.15-20 We
used updated information and recomputed hazard rate
ratios for these sites. To control for age and variations
in study procedures across the EPIC centres we strati-
fied the analyses by age (in 1 year categories) and cen-
tre.
All models were run separately formen andwomen,
and included the following potential confounders,
which were measured at recruitment: smoking
(never; past <10 years ago, ≥10 years ago; current
<15, 15-25, or ≥25 cigarettes/day, other (cigars, pipe,
cigarettes with missing dose)) and smoking duration
(<10, 10-<20, 20-<30, 30-<40, ≥40 years, missing
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(4.1%)); education (higher education/university, tech-
nical school, secondary school, primary school, none
or missing (1.2%)); physical activity (inactive, moder-
ately inactive, moderately active, active)21; body mass
index (BMI; kg/m²); consumption (g/day) of meat and
meat products, fish, fruits and vegetables; fibre, and
non-alcohol energy intake (kJ/day); and, for women,
menopausal status (premenopausal, postmenopausal/
surgical, perimenopausal), age at menarche (<13, 13/
14, >14 years, missing (30.8%)), and whether she had
ever breast fed (yes, no, or missing (32.9%)), ever used
oral contraceptives (yes, no, or missing (31.6%)), and
ever used hormone replacement therapy (yes, no, or
missing (30.6%)).
Restricted cubic spline regressions (knots: p10, p50,
p90 and p25, p50, p75) did not indicate deviation from
linearity of associations between alcohol and risk of
cancer among lifetime consumers, except for liver can-
cer in men (P<0.01 for non-linearity). We therefore
used regression coefficients (β) as risk functions to
express the risk for cancer incidence per 1 g/day incre-
ment in alcohol consumption among current lifetime
consumers. For simplicity and for comparability we
also used this approach for liver cancer in men.
We tested effectmodification by smoking for the site
specific cancers by includingproduct terms of smoking
status (never, former, current smoker) with alcohol (g/
day) and performing the likelihood ratio test between
nestedmodels. There was indication for an effectmod-
ification by smoking for upper aerodigestive tract and
liver cancer inmen and for colorectal cancer inwomen
(P<0.1).
Heterogeneity of hazard rate ratios across centres
was examined by the meta-analytic approach2223 and
by including interaction terms of centre and alcohol
(g/day) in the models and applying likelihood ratio
tests between nestedmodels. There was significant het-
erogeneity across centres for liver cancer in men and
colorectal cancer in women. Reasons for heterogeneity
are unknown.Reduction in alcohol consumption could
have been the consequence of pre-diagnostic diseases
(such as liver cirrhosis) or positive results on screening
(such as for liver functionmarkers or colon polyps) per-
formed in some but not all EPIC countries. This could
lead to reverse causation22425 and thus to attenuation of
the association between alcohol and cancer in these
centres, resulting in heterogeneity of the association
across centres. This speculation was supported by the
fact that the heterogeneity was no longer present when
we excluded the first four years of follow-up.
All statistical tests were two sidedwith significance at
the 5% level.
Alcohol attributable fractions
The computation of alcohol attributable fractions
requires not only the information on relative risks for
alcohol consumption (such as hazard rate ratios) but
also information on the distribution of alcohol con-
sumptionwithin the general population.Wecomputed
alcohol exposure data from the general population fol-
lowing an algorithm (triangulation)26 that combined
information of alcohol consumption from survey data
as reported by the World Health Organization27 and
per capita consumption28 for each country and sepa-
rately for men and women aged ≥15. These sex and
country specific data on alcohol exposure were mod-
elled as gamma function29 in current consumers of
alcohol by applying a formula30 based on the triangu-
lated populationmean alcohol intake (combining alco-
hol survey information with data on per capita alcohol
consumption).26 These gamma functions were shown
to fit and best model the right skewed distribution of
alcohol consumption on the population level. Further-
more, this exhibits the clear advantage of using alcohol
consumption continuously, as the estimation of alco-
hol attributable fractions based on alcohol categories
might lose valuable information. We also obtained
information on the proportions of never and former
consumers of alcohol from WHO, which used the
GENACIS survey as source of information, except
for Greece, for which data were derived from a
national survey on licit and illicit drug use.31 We then
calculated the country and sex specific alcohol attribu-
table fractions reflecting the burden of cancer inci-
dence associated with total alcohol consumption on
the population level (equation A, fig 1).
We also computed the part of the alcohol attributa-
ble fraction (partial alcohol attributable fraction) that
reflects the burden of cancer incidence associated
with alcohol consumption higher than the recom-
mended upper limit6 of two standard drinks a day
(>24 g/day) for men and one standard drink a day
(>12 g/day) in women (equation B, fig 1).
For adjusted risk estimates, the prevalence of expo-
sure among cases rather than among the general popu-
∫250 g/day
0.0001 g/day
Equation A
where PNC, PFC, and PLC = prevalence of never (%), former (%),
  or lifetime consumers (% and gamma distribution), respectively
HRR(x) = risk of cancer per consumed gram of alcohol a day for
  lifetime consumers
HRRFC = risk of cancer incidence in former compared with never
  consumers
where PLC >24 g/day = proportion of lifetime consumers with
  consumption larger than recommended upper limit
Counterfactual scenario for total and partial alcohol attributable
  fraction was complete elimination of alcohol consumption in
  population
AAF  =
PNC  
.1 + PFC  
.HRRFC + PLC  (x) 
.HRR(x)dx – 1
∫250 g/day
0.0001 g/day
PNC  
.1 + PFC  
.HRRFC + PLC  (x) 
.HRR(x)dx
∫250 g/day
24 g/day
Equation B
AAFMen >24 g/day  =
PLC  (x) 
.HRR(x)dx – PLC >24 g/day
∫250 g/day
0.0001 g/day
PNC  
.1 + PFC  
.HRRFC + PLC  (x) 
.HRR(x)dx
Fig 1 | Equations for computation of alcohol attributable
fractions
RESEARCH
BMJ | ONLINE FIRST | bmj.com page 3 of 10
lation should be used,32-36 which is hardly feasible
because no exposure information in cases from the gen-
eral population is available. We therefore performed
sensitivity analyses by simulating the distribution of
alcohol exposure among cases by using the alcohol
exposure information in cancer cases in the EPIC
study and shifting this curve towards the alcohol expo-
sure information of the general population (by deriving
weights by dividing the gamma distribution of the gen-
eral population by the gamma distribution of the EPIC
participants). Doing so, we simulated the alcohol expo-
sure distribution of cases as if they originated from the
general population. As expected, the estimated mean
alcohol consumption among cancer cases was higher
than among the general population. Alcohol attributa-
ble fractions were stratified by sex but not by country
because of sparse numbers of cases in some countries.
This was also why we applied this approach as a sensi-
tivity analysis and not as our main approach.
As smoking seemed to modify the association
between alcohol and cancers of the upper aero-
digestive tract and liver in men and colorectal cancer
in women, we also computed hazard rate ratios for
alcohol intake (continuous, per 12 g/day and for for-
mer v never consumers) and cancer incidence among
never smokers. For upper aerodigestive tract and liver
cancer the number of cases became low in men. We
therefore computed the hazard rate ratios in never
smokers for men and women combined with addi-
tional adjustment for sex. Alcohol attributable frac-
tions were recomputed by replacing the smoking
adjusted hazard rate ratios from the total EPIC cohort
by the hazard rate ratios in never smokers.
We used 10 000 Monte-Carlo simulated alcohol
attributable fractions, considering the uncertainty of
the hazard rate ratios, to compute the variances, stan-
dard errors, and corresponding 95% confidence inter-
vals of the alcohol attributable fractions.We estimated
the absolute number of alcohol attributable cancer
cases by multiplying the alcohol attributable fractions
with the total number of incidental cancer cases from
2008 derived from the GLOBOCAN 2008 project.13
The analyses were performedwith SAS, version 9.2,
and R, version 2.9.1.
RESULTS
Across the countries investigated, alcohol consump-
tion followed a north south gradient with Greece and
Spain having the highest proportions of never and for-
mer consumers, and Denmark and Germany having
the highest proportion of lifetime consumers (table 1).
This gradient was also seen for the proportions of alco-
hol consumption higher than the recommended upper
limit with Greece and Spain showing the lowest and
Germany and Denmark the highest proportions.
Amongmale and female lifetime consumers, the risk
for all the cancers we included increased with each
additional drink a day (table 2). Former consumption
compared with never was associated with a consider-
ably higher risk for total and alcohol related cancer in
men. We could not compute the risk for former con-
sumers of alcohol and upper aerodigestive tract and
liver cancer in men because of low number of cases in
those who had never consumed alcohol. Hence, we
Table 1 | Proportions of never, former, and lifetime consumers of alcohol and mean alcohol
consumption in lifetime consumers in general adult population aged 15 years or older
Country
Never
consumers (%)
Former
consumers (%)
Lifetime
consumers (%)
Mean*
(SD) g/day
% drinking over
daily recommended
upper limit†
Men
Denmark 0.6 2.5 96.9 32.9 (38.7) 42.6
Germany 1.3 2.6 96.1 34.9 (41.0) 43.8
Greece 6.7 9.3 84.0 27.4 (32.3) 32.4
Italy 5.8 3.9 90.3 30.1 (35.3) 37.3
Spain 9.5 23.4 67.1 33.0 (38.8) 29.5
UK 8.9 1.5 89.7 35.2 (41.4) 41.1
Total‡ 5.6 6.2 88.2 33.2 (39.0) 39.0
Women
Denmark 0.9 7.0 92.1 17.5 (21.5) 41.0
France 3.3 7.1 89.6 16.7 (20.6) 38.7
Germany 2.0 2.6 95.3 18.1 (22.3) 43.5
Greece 21.0 19.0 60.0 14.4 (17.9) 23.4
Italy 19.4 6.0 74.6 12.4 (15.6) 25.8
Netherlands 16.7 19.1 64.1 15.4 (18.1) 27.1
Spain 24.7 31.6 43.8 13.4 (16.7) 16.1
UK 15.2 2.9 81.9 17.6 (20.6) 37.7
Total‡ 11.7 9.0 79.3 15.9 (19.7) 33.2
*Mean alcohol consumption computed among lifetime consumers.
†>24 g/day in men; >12 g/day in women.
‡Weighted average by using population size data of population from each country.
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Fig 2 | Total and partial alcohol attributable fractions with 95%
confidence intervals and corresponding number of cases of
cancer with 95% confidence intervals in men in selected EPIC
countries (Italy, Spain, UK, Greece, Germany, Denmark) in
2008. UADT=upper aerodigestive tract
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computed alcohol attributable fractions for upper
aerodigestive tract and liver cancer in men based on
the hazard rate ratio for former alcohol consumption
and total cancer.
If we assume causality, these estimates would trans-
late into 10% (95% confidence interval 7% to 13%) of
total cancer in men (table 3) and 3.0% (1% to 5%) of
total cancer in women (table 4) being attributable to
alcohol consumption in these selected European coun-
tries. In both sexes the alcohol attributable fractionwas
highest for cancer of the upper aerodigestive tract (44%
(31% to 56%) in men; 25% (5% to 46%) in women),
followed by liver cancer (33% (11% to 54%) and 18%
(−3% to 38%), respectively). Alcohol consumptionwas
associatedwith 17% (10% to 25%) of cases of colorectal
cancer in men and 4% (−1% to 10%) in women. Also,
5% (2% to 8%) of cases of breast cancer inwomen could
be associated with total alcohol consumption. The
alcohol attributable fractions varied across countries
because of the differences in alcohol exposure, with
relatively high alcohol attributable fractions for Span-
ish men compared with men in other countries. Con-
fidence intervals of the alcohol attributable fractions,
however, overlapped for all countries in both men
and women.
Partial attributable fractions for alcohol consump-
tion higher than two drinks a day in men accounted
for 10% of colorectal cancer, 27% of liver cancer, and
38% of upper aerodigestive tract cancer (fig 2), which
accounted for 57% to 87% of the total alcohol attribu-
table fractions. The proportion of cancer associated
with alcohol consumption higher than the recom-
mended upper limit did not vary much by country in
men, except for Greece and Spain, where partial alco-
hol attributable fractions were somewhat lower
because of the lower proportions of men consuming
more than two drinks a day. In women, partial alcohol
attributable fractions accounted for 3% of colorectal
cancer, 4% of breast cancer, 7% of liver cancer, and
25% of upper aerodigestive tract cancer (fig 3), which
accounted for 40% to 98% of the total alcohol attribu-
table fractions. For all cancers investigated in women,
the partial alcohol attributable fraction was lowest in
Spain,Greece, and Italy and highest inGermany,Den-
mark, and the UK.When we compared total with par-
tial alcohol attributable fractions, a substantial part (40-
98%) of the incidence of alcohol attributable cancer
occurred because of alcohol consumption higher than
the recommended upper limit in both men and
women. The remaining part of the total alcohol attri-
butable fraction (2-60%) was associated with consump-
tion of less than the recommended upper limit and
former consumption. In men, about three in 100 alco-
hol related cancer cases were associated with alcohol
consumption of ≤24 g/day and more than 18 in 100
were associated with alcohol consumption >24 g/
day. In women one in 100 alcohol attributable cancer
cases was associated with alcohol consumption of
≤12 g/day and about four in 100 associated with alco-
hol consumption >12 g/day.
In terms of total numbers of cases of alcohol related
cancer, and if we accept that there is a causal associa-
tion between alcohol consumption and occurrence of
cancer, in 2008, 33 037 of 178 578 alcohol related can-
cer cases in men and 17 470 of 397 043 alcohol related
cancer cases in women were associated with alcohol
Table 2 | Adjusted hazard rate ratios (HRRs)* (95% confidence intervals) per 12 g/day
increment for lifetime consumers and for former versus never consumers (reference category)
of alcohol
Cancer site
Continuous (per 12 g/day)† Former consumers‡
No of cases HRR (95% CI) No of cases HRR (95% CI)
Men
Total cancer 5726 1.03 (1.02 to 1.04) 403 1.54 (1.20 to 1.98)
Alcohol related 1235 1.10 (1.07 to 1.12) 91 3.72 (1.81 to 7.65)
Upper aerodigestive tract 272 1.17 (1.12 to 1.23) — 1.54§ (1.20 to 1.98)
Colorectum 859 1.05 (1.02 to 1.09) 53 2.19 (0.99 to 4.83)
Liver 104 1.13 (1.04 to 1.22) — 1.54§ (1.20 to 1.98)
Women
Total cancer 12 467 1.03 (1.01 to 1.05) 776 1.10 (1.01 to 1.20)
Alcohol related 6671 1.05 (1.03 to 1.07) 354 1.04 (0.92 to 1.19)
Upper aerodigestive tract 113 1.25 (1.10 to 1.42) 9 0.65 (0.27 to 1.56)
Colorectum 1245 1.04 (0.99 to 1.09) 79 1.05 (0.79 to 1.40)
Liver 54 1.09 (0.89 to 1.33) 10 2.28 (0.89 to 5.85)
Breast 5259 1.05 (1.02 to 1.07) 256 1.03 (0.88 to 1.20)
*Adjusted for smoking (dose and duration); education; physical activity; BMI; consumption of meat, fish, fruit
and vegetables; fibre, and non-alcoholic energy intake (kJ/day); and, for women additionally, menopausal
status, age at menarche, breast feeding, oral contraceptive use, hormone replacement therapy.
†Among lifetime consumers (102 648 men, 216 149 women). Log linear estimates used to establish risk
functions.
‡Reference category=never consumers of alcohol.
§When there were no or a limited number of cases in reference category of never consumers, HRR for total
cancer was used.
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consumption ofmore than two (one for women) drinks
a day. Cancer of the upper aerodigestive tract
accounted for the highest number of alcohol attributa-
ble cases inmen (22 022 cases), withGermany showing
most cases (table 5). In women, breast cancer contrib-
utedmost to the number of alcohol attributable cancer
cases with 12 589 cases (fig 2, table 5). The numbers of
total alcohol attributable cancer cases varied consider-
ably by country, mainly because of different popula-
tion sizes in the investigated countries but also
because of varying alcohol attributable fractions across
the countries.
The sensitivity analysis using the alcohol consump-
tion data in the cancer cases only had similar results to
those in tables 3 and 4 (data not shown). The maxi-
mum deviation was 3 percentage points in men for
alcohol related cancers (29% v 32%) and 2 percentage
points in women for upper aerodigestive tract cancer
(23% v 25%).
Given there is a causal association between alcohol
consumption and risk of cancer in people who have
never smoked, sensitivity analyses with the hazard
rate ratios of never smokers indicated noticeable differ-
ences comparedwith alcohol attributable fractions that
were based on hazard rate ratios adjusted for smoking
from the total cohort, particularly for liver cancer, for
which the alcohol attributable fraction inmenwho had
never smoked (AAFSens) was 78% compared with 33%
in the total population, and for upper aerodigestive
tract cancer, for which theAAFSens was 14% compared
with 44%. The alcohol attributable fractions for color-
ectal cancer in women differed by 3 percentage points
with AAFSens 1% v 4%, which was, however, within the
confidence interval computed for the alcohol attribu-
table fraction based on estimates of the total cohort.
DISCUSSION
If we assume causality, our analysis shows that about
10% of total cancer in men and 3% in women could be
attributed to current and former alcohol consumption
in the European countries included in this study. In
relative terms, the alcohol attributable fraction of can-
cer incidence was highest for cancer of the upper aero-
digestive tract, followed by liver cancer. The highest
absolute number of alcohol attributable cancer cases
in men was found for upper aerodigestive tract and in
women for breast cancer. Furthermore, a substantial
part of the alcohol attributable cancer cases were asso-
ciated with consumption of more than two or one stan-
dard drinks per day for men and women, respectively.
Comparison with other studies
Few previous studies have reported on alcohol attribu-
table mortality37-43 or incidence45 44 45 of cancer. Pub-
lished estimates for alcohol attributable incidence of
cancer in Europe38 and France44 were of similar mag-
nitude to our estimates. For women both higher545 and
lower44 alcohol attributable fractions for single cancer
sites were reported. Differences could emerge because
we considered also the risk of cancer associated with
former consumption of alcohol, or because of the risk
functions used by one study,44 which were not derived
for men and women separately,46 or because of the dif-
ferent application of alcohol exposure data. One Brit-
ish study used population means of alcohol
consumption,5 while we applied gamma distributions,
which better represent the right skewness of the data on
alcohol consumption. Because of the various methods
used to compute the alcohol attributable fractions in
previous studies and because of limited data, no com-
parable estimates across the European countries on the
alcohol attributable burden of cancer have been avail-
able until now.
Besides the total burden, we also quantified the bur-
den of cancer incidence associated with exceeding the
recommended maximal daily limit of alcohol. We
found that a substantial part of this incidence was asso-
ciated with consumption above the recommended
upper limit, indicating the potential for cancer preven-
tion merely by adhering to the current recommenda-
tions. For cancer sites with markedly higher risks for
former comparedwith never consumers—such as liver
cancer—a noticeable part of the total alcohol attribu-
table fractions was associated with former consump-
tion. That also explains why for those cancers the
partial alcohol attributable fractions associated with
consumption above the recommended upper limit
were lower than for cancers with less strong risk esti-
mates in former consumers, such as breast cancer.
Alcohol consumption below the recommended
upper limit accounted for a modest part of the total
alcohol attributable fraction of alcohol related cancers,
with at least three in 100 cases of cancer inmen andone
in 100 cases in women. This shows that following the
current recommendation would not eliminate alcohol
attributable cancer incidence completely. In contrast,
for all cause mortality alcohol consumption is often
shown to be associated with a lower risk for up to
four drinks a day in men and two drinks a day in
women.47 This lower risk is probably because of the
lower risk of death from cardiovascular disease,
Table 3 | Proportion of cancer cases attributable to alcohol use in men aged ≥15 years. Figures are percentages (95%
confidence interval)
Cancer site Denmark Germany Greece Italy Spain UK Total
Total cancer 8 (5 to 12) 9 (5 to 12) 10 (7 to 12) 8 (5 to 11) 15 (13 to 17) 8 (5 to 11) 10 (7 to 13)
Alcohol related 29 (22 to 35) 30 (23 to 37) 33 (29 to 36) 28 (23 to 33) 46 (44 to 49) 27 (21 to 34) 32 (27 to 38)
Upper aerodigestive tract 45 (32 to 57) 47 (34 to 60) 37 (26 to 47) 40 (29 to 52) 41 (31 to 51) 45 (32 to 58) 44 (31 to 56)
Colorectum 15 (7 to 24) 16 (7 to 25) 18 (12 to 23) 15 (8 to 22) 28 (23 to 32) 14 (5 to 23) 17 (10 to 25)
Liver 34 (10 to 57) 35 (11 to 59) 28 (10 to 45) 30 (9 to 51) 32 (15 to 49) 33 (10 to 57) 33 (11 to 54)
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especially coronary heart disease and ischaemic
stroke.48-50 Heavy alcohol consumption above the
recommended upper limit, however, was shown to be
not related to48 or detrimental for46 cardiovascular dis-
eases, whereas for cancer, as shown by many
studies46 51 including ours, there is no sensible limit
belowwhich the risk of cancer is decreased. Therefore,
even though light to moderate alcohol consumption
might decrease the risk for cardiovascular disease and
mortality, the net effect of alcohol is harmful.1 Thus,
alcohol consumption should not be recommended to
prevent cardiovascular disease or all cause mortality.
Sensitivity analysis
Smoking, known to be closely related to alcohol con-
sumption, could be a potential synergistic risk factor,
particularly for cancer of the upper aerodigestive tract.
A possible synergistic effect modification of smoking
on the risk of alcohol and cancer could lead to an over-
estimation of the alcohol attributable fraction.52 We
observed a substantially higher alcohol attributable
fraction for liver cancer and a considerably lower alco-
hol attributable fraction for upper aerodigestive tract
cancer in men when we applied the hazard rate ratios
for alcohol consumption amongnever smokers. Poten-
tial effect modification by smoking was also indicated
for colorectal cancer in women, for which the alcohol
attributable fraction computed by using hazard rate
ratios among never smokerswas lower than the overall
alcohol attributable fraction, but within the 95%
confidence interval. In the groups of never smokers
the number of cases of cancer was limited in the
EPIC study, which led to a limited power to assess
the association between the consumption of alcohol
and risk of cancer in this subgroup. This could be one
explanation why the alcohol attributable fractions dif-
fered from the originally computed overall alcohol
attributable fractions. We could also have overesti-
mated the alcohol attributable fraction for upper aero-
digestive tract cancer in men because of the effect of
smoking.However, a recent pooled analysis of 17 Eur-
opean andAmerican case-control studies investigating
people who had ever consumed alcohol compared
with those who had never consumed alcohol in rela-
tion to head and neck cancer in people who had never
smoked,4 53 estimated a population attributable frac-
tion of 29.5% in men and 31.5% women. These esti-
mates are of similar magnitude to our estimates based
on results from the total EPIC study population, sug-
gesting the estimates of our overall alcohol attributable
fractions to be valid. Regarding liver cancer, smoking
is a recognised causal risk factor.3 Thus, there is no
plausible explanation for the substantial higher alcohol
attributable fraction for liver cancer based on risk esti-
mates computed in those who had never smoked.
Therefore, the limited power because of low numbers
of cases and the resulting imprecise point estimates of
the hazard rate ratios in never smokers is themost plau-
sible explanation for the considerably higher alcohol
attributable fraction of liver cancer.
Table 4 | Proportion of cancer cases attributable to alcohol use in women aged ≥15 years. Figures are percentages (95% confidence interval)
Cancer site Denmark France Germany Greece Italy Netherlands Spain UK Total
Total cancer 3 (1 to 5) 3 (1 to 5) 3 (1 to 5) 3 (2 to 4) 2 (1 to 3) 3 (2 to 5) 4 (3 to 5) 3 (1 to 5) 3 (1 to 5)
Alcohol related 7 (4 to 10) 6 (4 to 9) 7 (4 to 10) 4 (3 to 6) 4 (2 to 6) 5 (3 to 7) 4 (3 to 5) 6 (3 to 9) 5 (3 to 8)
Upper aerodigestive tract 32 (9 to 55) 30 (8 to 52) 35 (11 to 59) 15 (−1 to 31) 18 (4 to 32) 17 (0 to 34) 5 (−8 to 18) 30 (9 to 51) 25 (5 to 46)
Colorectum 5 (−2 to 12) 5 (−1 to 11) 6 (−2 to 13) 4 (0 to 7) 3 (−1 to 7) 4 (0 to 8) 3 (1 to 6) 5 (−2 to 11) 4 (−1 to 10)
Liver 18 (−8 to 44) 17 (−7 to 42) 15 (−16 to 46) 24 (12 to 36) 13 (−3 to 29) 24 (11 to 38) 31 (24 to 38) 13 (−13 to 39) 18 (−3 to 38)
Breast 6 (3 to 10) 6 (3 to 9) 7 (3 to 10) 4 (2 to 6) 4 (2 to 6) 4 (2 to 6) 3 (2 to 4) 5 (2 to 8) 5 (2 to 8)
Table 5 | Total number* of alcohol attributable cancer cases for general population in 2008 in selected countries
Cancer site Denmark France Germany Greece Italy Netherlands Spain UK Total
Men
Total 1313 NA 22 388 1968 14 556 NA 18 173 12 564 71 519
Alcohol related 996 NA 17 967 1107 12 332 NA 14 295 9299 57 596
Upper aerodigestive tract 445 NA 7864 351 7045 NA 4236 5133 22 022
Colorectum 348 NA 6053 318 4206 NA 4602 2936 18 836
Liver 64 NA 1797 178 2414 NA 1170 700 6465
Women
Total 503 4415 6561 524 3254 1282 2996 3791 23 307
Alcohol related 459 4 717 7240 293 2076 939 1376 4058 21 520
Upper aerodigestive tract 146 1 359 1698 39 528 217 395 1589 5499
Colorectal 116 923 1771 59 744 221 411 787 4919
Liver 13 269 376 78 529 29 442 169 2020
Breast 259 2 956 4193 177 1734 550 680 2498 12 589
NA=not applicable.
*Numbers refer to total burden of incident cancer cases associated with current and former alcohol consumption in population. Sum of cases for
single countries might not exactly add to total number of cases because of country specific estimation of numbers and separate estimation for all
countries combined.
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Advantages and limitations
Our results are limited by the underlying data quality
to generate the relative risk functions and by the data
on alcohol exposure. The risk estimates were adjusted
for several confounders—for example, dietary factors
or extensive adjustment for smoking, the main con-
founder for the association between alcohol and risk
of cancer. Different confounding in the various coun-
tries we investigated is unlikely to play a major role
because the relative risk estimates were observed to
be relatively homogenous across the countries. Also,
the relative risk estimates are in line with results from
meta-analyses24 46 54 and with the evaluation of the car-
cinogenicity of alcohol,26 which supports the validity of
our effect estimates for alcohol consumption and risk
of cancer. Loss to follow-up, though low, could have
led to underestimation of the risk of cancer, as high risk
or exposed people are more likely to be lost to follow-
up. Recall bias is unlikely to have had an impact on the
relative risk estimates as the exposure information was
assessed before the cancer occurred. Also, under-
reporting of alcohol consumption because of social
desirability should not have affected our risk estimates,
assuming that under-reporting was independent of
later case and non-case status and that this did not
change the ranking of the study participants. As the
EPIC study population is a convenience sample, the
transferability of study results to the general popula-
tion could be questioned. Selective participation, how-
ever, should not impair aetiological conclusions
expressed as relative risk estimates because these effect
measures are both internally and externally valid.855
The data on alcohol consumption were representa-
tive for the countries investigated, and they were quan-
tified comparably across all countries.27 Thus, the
exposure information is highly comprehensive and
comparable, resulting in directly comparable alcohol
attributable fractions across the selected countries.
Comparison of previous country specific alcohol attri-
butable fraction estimates was impeded as the studies
used different methods and strategies to compute the
alcohol attributable burden of cancer incidence.4 5 44 45
As the prevalence of alcohol exposure differs across
the European countries, however, we would also
expect the burden of alcohol attributable cancer inci-
dence to differ across the countries, which is of poten-
tial interest for public health policy makers.
We have provided a systematic and comparable
overview of the alcohol attributable cancer incidence
for several European countries, and presented alcohol
attributable fractions for causally related cancer sites
based on empirical original data for both the total (cur-
rent and former) alcohol consumption as well as for
alcohol consumption higher than the recommended
upper limit. We considered the risk from former alco-
hol consumption and could thus capture, in contrast
with previous studies, the full burden of cancer inci-
dence associated with alcohol consumption. The
gamma distributions we used for current alcohol con-
sumption overcome the limitation of using categorical
risk estimates and categories of proportions of alcohol
consumption. This is of particular value because the
risk of cancer increases linearly and alcohol consump-
tion follows a strongly right skewed distribution. The
attributableburdenof cancer incidence associatedwith
consuming above the recommended upper limit illus-
trates the potential of avoidable cancer incidence, if the
recommendations of the WCRF/AICR6 are followed.
Until now, it was only speculated that reducing alcohol
consumption to two drinks a day inmen and one drink
a day in women would be beneficial in terms of inci-
dence of cancer. We have now computed quantitative
measures, both relative (alcohol attributable fraction)
and absolute (total number of cancer cases), for the
burden associated with alcohol consumption above
the recommended upper limit.
Conclusions and policy implications
In conclusion, if we assume causality between alcohol
consumption and overall and specific cancer inci-
dence, a considerable proportion of the most common
and most lethal cancers is attributable to former and
current alcohol consumption in the selected European
countries, especially to consumption above the recom-
mended upper limit. This strongly underlines the
necessity to continue and to increase efforts to reduce
alcohol consumption in Europe,56 both on the indivi-
dual and the population level.
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